{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312711/0/en/Nexalin-Technology-Announces-Two-Clinical-Abstracts-Accepted-for-Presentation-at-the-2026-NYC-Neuromodulation-Conference-Highlighting-Preliminary-Clinical-Results-Across-Anxiety-De.html", "message": "News view counter 801935 successfully enlarged"}